Search research articles
Contact Us
Filters
Showing results (81-90 of 208) with videos related to
Page
of 21
Sort By:
Life Sciences
|
January 1, 1983
Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine
A E Jacobson, B S Bajwa, R A Streaty, et al.
Neuropeptides
|
May 1, 1984
Morphine noncompetitively inhibits [3H]leucine enkephalin binding to membranes lacking type-II delta binding sites: evidence for a two-site allosteric model
R B Rothman, C B Pert, A E Jacobson, et al.
The Journal of Organic Chemistry
|
May 17, 1974
Synthesis of 2,9beta-dimethyl-6,7-benzomorphan
T Oh-Ishi, A E Jacobson, R S Wilson, et al.
Molecular Pharmacology
|
December 1, 1989
The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites
R B Rothman, A A Reid, J A Monn, et al.
Biochemical Pharmacology
|
February 1, 1988
Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes
W D Bowen, P A Rodrigues, T E Wanzor, et al.
Journal of Medicinal Chemistry
|
December 1, 1984
Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-ones
H Schmidhammer, L Aeppli, L Atwell, et al.
Neuropeptides
|
December 1, 1984
Probes for narcotic receptor mediated phenomena. 10. Irreversible ligands to opioid receptors based on biologically potent endoethenooripavines. Reversible binding of fit to mu and delta opioid receptors
R A Lessor, K C Rice, R A Streaty, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1985
Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells
W F Simonds, T R Burke, K C Rice, et al.
Journal of Pharmaceutical Sciences
|
February 1, 1977
Potential long acting opiate antagonists: preparation, pharmacological activity, and opiate-receptor binding of N-substituted 2'-hydroxy-5-methyl-9 alpha-propyl-6,7-benzomorphans
K C Rice, W A Klee, M D Aceto, et al.
Journal of Neuroimmunology
|
June 1, 1990
Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway
D J Carr, B R DeCosta, A E Jacobson, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 208) with videos related to
Sort By:
Page
of 21
Life Sciences
|
January 1, 1983
Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine
A E Jacobson, B S Bajwa, R A Streaty, et al.
Neuropeptides
|
May 1, 1984
Morphine noncompetitively inhibits [3H]leucine enkephalin binding to membranes lacking type-II delta binding sites: evidence for a two-site allosteric model
R B Rothman, C B Pert, A E Jacobson, et al.
The Journal of Organic Chemistry
|
May 17, 1974
Synthesis of 2,9beta-dimethyl-6,7-benzomorphan
T Oh-Ishi, A E Jacobson, R S Wilson, et al.
Molecular Pharmacology
|
December 1, 1989
The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites
R B Rothman, A A Reid, J A Monn, et al.
Biochemical Pharmacology
|
February 1, 1988
Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes
W D Bowen, P A Rodrigues, T E Wanzor, et al.
Journal of Medicinal Chemistry
|
December 1, 1984
Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-ones
H Schmidhammer, L Aeppli, L Atwell, et al.
Neuropeptides
|
December 1, 1984
Probes for narcotic receptor mediated phenomena. 10. Irreversible ligands to opioid receptors based on biologically potent endoethenooripavines. Reversible binding of fit to mu and delta opioid receptors
R A Lessor, K C Rice, R A Streaty, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1985
Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells
W F Simonds, T R Burke, K C Rice, et al.
Journal of Pharmaceutical Sciences
|
February 1, 1977
Potential long acting opiate antagonists: preparation, pharmacological activity, and opiate-receptor binding of N-substituted 2'-hydroxy-5-methyl-9 alpha-propyl-6,7-benzomorphans
K C Rice, W A Klee, M D Aceto, et al.
Journal of Neuroimmunology
|
June 1, 1990
Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway
D J Carr, B R DeCosta, A E Jacobson, et al.
Page
of 21